FIELD: medicine.
SUBSTANCE: occluder is introduced into the middle cerebral artery from the side of focal ischemia modeling. The external carotid and common carotid arteries are isolated and clamped; the wall of the common carotid artery is perforated above the clipping site and an occluder made of a monofilament synthetic resorbable suture material based on polyclocalide is introduced into the middle cerebral artery along the general and internal carotid arteries. Then the common carotid artery is clamped from the opposite side.
EFFECT: method allows to reduce traumatism and increase method reproducibility, which is achieved due to the sequence of the above methods.
1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING MALIGNANT ISCHEMIC STROKE | 2023 |
|
RU2822706C1 |
| METHOD FOR SIMULATING MALIGNANT ISCHEMIC STROKE | 2022 |
|
RU2785608C1 |
| METHOD FOR MODELING ISCHEMIC INSULT | 1999 |
|
RU2211672C2 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| METHOD OF TREATING CEREBRAL ISCHEMIA | 2008 |
|
RU2408300C2 |
| METHOD FOR SIMULATING DEVELOPMENT OF FOCAL CEREBRAL HAEMORRHAGE IN BRAIN CORTEX OF NEWBORN RATS | 2012 |
|
RU2505865C1 |
| METHOD FOR MODELING FOCAL ISCHEMIC STROKE OF BRAIN | 2020 |
|
RU2756427C1 |
| HYBRID PROTEIN IGF-1-LONG FOR TREATING STROKE, NUCLEIC ACID, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 2018 |
|
RU2711111C1 |
| METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
| SURGICAL METHOD FOR TREATING SEGMENTAL STENOSIS OF EXTRACRANIAL SEGMENT OF INTERNAL CAROTID ARTERY | 1997 |
|
RU2145195C1 |
